Literature DB >> 27416757

Pathways to mitochondrial dysfunction in ALS pathogenesis.

Maria Teresa Carrì1, Nadia D'Ambrosi2, Mauro Cozzolino3.   

Abstract

Alterations in the structure and functions of mitochondria are a typical trait of Amyotrophic Lateral Sclerosis, a neurodegenerative disease characterized by a prominent degeneration of upper and lower motor neurons. The known gene mutations that are responsible for a small fraction of ALS cases point to a complex interplay between different mechanisms in the disease pathogenesis. Here we will briefly overview the genetic and mechanistic evidence that make dysfunction of mitochondria a candidate major player in this process.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Amyotrophic Lateral Sclerosis; Mitochondria; Mitophagy; Protein aggregation

Mesh:

Year:  2016        PMID: 27416757     DOI: 10.1016/j.bbrc.2016.07.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes.

Authors:  Arianna Russo; Raffaella Scardigli; Federico La Regina; Melissa E Murray; Nicla Romano; Dennis W Dickson; Benjamin Wolozin; Antonino Cattaneo; Marcello Ceci
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

2.  ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.

Authors:  Yajuan Xiao; Chehade Karam; Jianxun Yi; Lin Zhang; Xuejun Li; Dosuk Yoon; Huan Wang; Kamal Dhakal; Paul Ramlow; Tian Yu; Zhaohui Mo; Jianjie Ma; Jingsong Zhou
Journal:  Pharmacol Res       Date:  2018-09-18       Impact factor: 7.658

Review 3.  NAD+ in Brain Aging and Neurodegenerative Disorders.

Authors:  Sofie Lautrup; David A Sinclair; Mark P Mattson; Evandro F Fang
Journal:  Cell Metab       Date:  2019-10-01       Impact factor: 27.287

Review 4.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

5.  From Physiological Properties to Selective Vulnerability of Motor Units in Amyotrophic Lateral Sclerosis.

Authors:  Marcin Bączyk; Marin Manuel; Francesco Roselli; Daniel Zytnicki
Journal:  Adv Neurobiol       Date:  2022

6.  Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate.

Authors:  Shinichiro Maki; Md Shafiqul Islam; Tomohito Itoh; Masanobu Nurimoto; Akira Yabuki; Yu Furusawa; Hiroaki Kamishina; Yui Kobatake; Tofazzal Md Rakib; Martia Rani Tacharina; Osamu Yamato
Journal:  Animals (Basel)       Date:  2022-06-27       Impact factor: 3.231

Review 7.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 8.  Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model.

Authors:  Jingsong Zhou; Ang Li; Xuejun Li; Jianxun Yi
Journal:  Arch Biochem Biophys       Date:  2019-01-22       Impact factor: 4.013

9.  Lysosomes Dysfunction Causes Mitophagy Impairment in PBMCs of Sporadic ALS Patients.

Authors:  Matteo Bordoni; Orietta Pansarasa; Eveljn Scarian; Riccardo Cristofani; Roberta Leone; Valentina Fantini; Maria Garofalo; Luca Diamanti; Stefano Bernuzzi; Stella Gagliardi; Stephana Carelli; Angelo Poletti; Cristina Cereda
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

10.  All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice.

Authors:  Yu Zhu; Yue Liu; Fang Yang; Wenzhi Chen; Jianxian Jiang; Pei He; Shishi Jiang; Menhua Li; Renshi Xu
Journal:  Mol Neurobiol       Date:  2020-06-17       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.